Post

Meet Tina: The AI assistant that monitors neurodegenerative disease regression

During clinical trials of neurodegenerative diseases such as Parkinson’s disease and Alzheimer’s disease, patients have frequent face time with their …

Lucid Diagnostics target oesphageal cancer with early testing

Lishan Aklog, the CEO of US-based cancer prevention company Lucid Diagnostics, called attention to Lucid's EsoCheck cell collection device during …

New UK medical device industry body Team-AB officially launches

A new UK industry body designed to help medical device regulators navigate the new legal landscape of a post-Brexit Britain …

Werfen secures CE mark for antiphospholipid syndrome assays

Werfen has received CE marking for its Aptiva antiphospholipid syndrome (APS) Immunoglobulin G (IgG) and Immunoglobulin M (IgM) reagents, meaning …

Nexsen lands $3.5m to support rapid strep test development

Nexsen Biotech has won A$5.5m ($3.56m) in Australian Federal Government and University support for the clinical development of a rapid …